title: [Edoxaban is safer than vitamin K antagonists].
authors.forename: Dirk
authors.initials: D
authors.lastname: Einecke
mesh_terms: D000284:Administration, Oral; D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use*; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D011655:Pulmonary Embolism / Q000188:drug therapy*; D011725:Pyridines / Q000009:adverse effects* / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D055502:Secondary Prevention; D013844:Thiazoles / Q000009:adverse effects* / Q000627:therapeutic use*; D020246:Venous Thrombosis / Q000188:drug therapy*; D014812:Vitamin K / Q000037:antagonists & inhibitors*; D014859:Warfarin / Q000009:adverse effects* / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D011725:Pyridines; D013844:Thiazoles; D014812:Vitamin K; D014859:Warfarin; C552171:edoxaban